Tooth enamel hydroxyapatite and acquired dental pellicle (HA/AEP)

Tooth enamel is the most highly mineralized tissue in the human body, consisting primarily of hydroxyapatite crystals arranged in a complex prismatic structure [StatPearls: Tooth Enamel]. The acquired dental pellicle is a biological film that forms instantaneously on the enamel surface upon exposure to saliva, composed of selectively adsorbed proteins, glycoproteins, and lipids [PubMed: PMID 25653308]. This interface serves as a critical protective barrier, regulating the diffusion of acids and ions and acting as a lubricant to prevent wear [PubMed: PMID 11413928]. In dental pharmacology, this surface is the primary target for remineralizing agents such as fluoride, which enhances the structural integrity of the enamel by forming fluorapatite [CDC: Fluoridation Basics]. Furthermore, the pellicle is the site of initial microbial attachment, making it a key target for anti-adhesive and antimicrobial therapies designed to prevent dental caries and periodontal disease [PubMed: PMID 16922335]. Understanding the physicochemical interactions at this surface is essential for developing treatments for dental erosion and dentin hypersensitivity [PubMed: PMID 21247930].

Other names

Enamel surfaceHydroxyapatite crystalAcquired enamel pellicle (AEP)Salivary pellicleDental enamel

The primary mechanism of action involves the ionic exchange and precipitation of minerals onto the hydroxyapatite lattice, specifically the substitution of hydroxyl groups with fluoride to form acid-resistant fluorapatite [StatPearls: Fluoride]. Additionally, the acquired dental pellicle is modified by the adsorption of therapeutic agents like chlorhexidine, which provides a substantivity effect, slowly releasing antimicrobial ions to inhibit bacterial colonization [PubMed: PMID 16922335]. Other agents like CPP-ACP maintain a state of supersaturation of calcium and phosphate ions at the enamel surface, driving remineralization and inhibiting demineralization [PubMed: PMID 15153690]. Occluding agents target the surface to block dentinal tubules, thereby treating hypersensitivity [PubMed: PMID 21247930].